Five things for pharma marketers to know: Monday, January 9,

Pfizer discusses license for generic Paxlovid treatment with China; AbbVie spends $30 million upfront for Immunome partnership to bolster antibody research.

Related Keywords

China , Netherlands , Chinese , Dutch , Steve Davidsen , Amgen , Pfizer , Cytomx Therapeutics Inc , Reuters , Discovery Engine , Emergence Therapeutics , Endpoints News , Cytomx Therapeutics ,